|
Pathophysiology
Citations 631-640 of 1276 total displayed.
|
Past content
(since Jan 1999):
|
- Clinical Investigations and Reports
Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores
- Paul M Ridker and Nancy Cook
Circulation 2004;109:1955-1959; published online before print as doi:10.1161/01.CIR.0000125690.80303.A8
[Abstract]
[Full text]
- Basic Science Reports
Caspase-3 and Tissue Factor Expression in Lipid-Rich Plaque Macrophages: Evidence for Apoptosis as Link Between Inflammation and Atherothrombosis
- Randolph Hutter, Carolina Valdiviezo, Bernhard V. Sauter, Mikko Savontaus, Igor Chereshnev, Francine E. Carrick, Gerhard Bauriedel, Berndt Lüderitz, John T. Fallon, Valentin Fuster, and Juan J. Badimon
Circulation 2004;109:2001-2008; published online before print as doi:10.1161/01.CIR.0000125526.91945.AE
[Abstract]
[Full text]
- Basic Science Reports
B7-1/B7-2 Costimulation Regulates Plaque AntigenSpecific T-Cell Responses and Atherogenesis in Low-Density Lipoprotein ReceptorDeficient Mice
- Chiara Buono, Hong Pang, Yasushi Uchida, Peter Libby, Arlene H. Sharpe, and Andrew H. Lichtman
Circulation 2004;109:2009-2015; published online before print as doi:10.1161/01.CIR.0000127121.16815.F1
[Abstract]
[Full text]
- Basic Science Reports
Conformational Rearrangement in C-Reactive Protein Is Required for Proinflammatory Actions on Human Endothelial Cells
- Tarek Khreiss, Levente József, Lawrence A. Potempa, and János G. Filep
Circulation 2004;109:2016-2022; published online before print as doi:10.1161/01.CIR.0000125527.41598.68
[Abstract]
[Full text]
- Articles
Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans
- Abu S.M. Shamsuzzaman, Mikolaj Winnicki, Robert Wolk, Anna Svatikova, Bradley G. Phillips, Diane E. Davison, Peter B. Berger, and Virend K. Somers
Circulation published April 26, 2004, doi:10.1161/01.CIR.0000127960.28627.75
[Abstract]
- Articles
Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor- B Activation in Human Endothelial Cells
- Wei Gen Li, Dan Gavrila, Xuebo Liu, Lixing Wang, Skuli Gunnlaugsson, Lynn L. Stoll, Michael L. McCormick, Curt D. Sigmund, Chaosu Tang, and Neal L. Weintraub
Circulation published April 26, 2004, doi:10.1161/01.CIR.0000127956.43874.F2
[Abstract]
- Articles
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
- Stefan Kiechl, Georg Schett, Gregor Wenning, Kurt Redlich, Martin Oberhollenzer, Agnes Mayr, Peter Santer, Josef Smolen, Werner Poewe, and Johann Willeit
Circulation published April 26, 2004, doi:10.1161/01.CIR.0000127957.43874.BB
[Abstract]
- Special Review
Asymmetrical Dimethylarginine: The Über Marker?
- John P. Cooke
Circulation 2004;109:1813-1818, doi:10.1161/01.CIR.0000126823.07732.D5
[Full text]
- Basic Science Reports
Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence
- Sucharit Bhakdi, Michael Torzewski, Kerstin Paprotka, Steffen Schmitt, Hala Barsoom, Prapat Suriyaphol, Shan-Rui Han, Karl J. Lackner, and Matthias Husmann
Circulation 2004;109:1870-1876; published online before print as doi:10.1161/01.CIR.0000124228.08972.26
[Abstract]
[Full text]
- Articles
Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death
- Aaron E. Cozen, Hideaki Moriwaki, Michal Kremen, Mary Beth DeYoung, Helén L. Dichek, Katherine I. Slezicki, Stephen G. Young, Murielle Véniant, and David A. Dichek
Circulation published April 19, 2004, doi:10.1161/01.CIR.0000127369.24127.03
[Abstract]
|
|